(15:42 GMT) NewAmsterdam Pharma Price Target Raised to $51.00/Share From $47.00 by RBC Capital
Dow Jones Newswires
NewAmsterdam Pharma Is Maintained at Outperform by RBC Capital
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:NAMS
- Language
- English